These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 66549)

  • 21. Symptomatic renal osteodystrophy after renal transplantation: treatment with 1-alpha-hydroxycholecalciferol.
    Williams PS; Hillis AN; Carty AJ; Sells RA; Bone JM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2227-8. PubMed ID: 3274500
    [No Abstract]   [Full Text] [Related]  

  • 22. [Uremic renal osteodystrophy].
    Marco Franco JE; Alarcon Zurita A; Piza Buñola C; Morey Molina A; Bestard Palmer J; Mairata Bosch S
    Rev Clin Esp; 1983 Feb; 168(3):153-7. PubMed ID: 6346408
    [No Abstract]   [Full Text] [Related]  

  • 23. [Diagnostic image (35). Epiphysiolysis of the knee due to renal osteodystrophy].
    Beek FJ
    Ned Tijdschr Geneeskd; 2001 Apr; 145(17):822. PubMed ID: 11370427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Interferences between pulmonology and nephrology: renal osteodystrophy--multiple brown tumors].
    Bîlha C
    Pneumologia; 2004; 53(1):31-5. PubMed ID: 18210719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapy of uremic osteopathy. II. Effect of 5,6-trans-25-hydroxycholecalciferol in terminal kidney insufficiency].
    von Herrath D; Kraft D; Grigoleit HG; Schaefer K
    Dtsch Med Wochenschr; 1973 Jul; 98(28):1379-81. PubMed ID: 4197778
    [No Abstract]   [Full Text] [Related]  

  • 26. [Long-term effects of a combination of 25-hydroxycholecalciferol and 1-alpha-hydroxycholecalciferol on osteodystrophy in chronic hemodialysis patients].
    Sebert JL; Marie A; Kuntz D; Marie P; Gueris J; Smadja A; Fournier A; Quichaud J
    Rev Rhum Mal Osteoartic; 1981; 48(7-9):535-41. PubMed ID: 7291931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bone scintillography with strontium 85. A new application of the method in the study of patients with renal osteodystrophy].
    Treviño-Becerra A; Hernández del Río A; Bárcena-Villegas JA; Cuarón A; Torres-Zamora M
    Arch Invest Med (Mex); 1972; 3(3):491-502. PubMed ID: 4660808
    [No Abstract]   [Full Text] [Related]  

  • 28. [Letter to the authors of the "Recommendations for clinical practice" concerning the prevention of renal osteodystrophy before extra-renal purification].
    Fournier A; Aparicio M
    Nephrologie; 1998; 19(3):129-30. PubMed ID: 9633056
    [No Abstract]   [Full Text] [Related]  

  • 29. [Renal osteodystrophy during chronic dialysis and transplantation].
    Fournier A; Bordier P; Weil B; Safar M; Idatte JM
    Presse Med (1893); 1971 Oct; 79(45):2007-8. PubMed ID: 4940843
    [No Abstract]   [Full Text] [Related]  

  • 30. Osteodystrophy in patients with chronic renal failure.
    Fearing MO
    Nurs Clin North Am; 1975 Sep; 10(3):461-8. PubMed ID: 1041628
    [No Abstract]   [Full Text] [Related]  

  • 31. Osteodystrophy developing spontaneously in the course of chronic renal failure.
    Stanbury SW; Lumb GA; Mawer EB
    Arch Intern Med; 1969 Sep; 124(3):274-81. PubMed ID: 5806041
    [No Abstract]   [Full Text] [Related]  

  • 32. [Mineral and bone disorder in chronic kidney disease].
    Matuszkiewicz-Rowińska J; Kulicki P
    Wiad Lek; 2014; 67(3):419-21. PubMed ID: 25782203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Renal osteodystrophy and its possible correction in patients on chronic hemodialysis].
    Rozental' RL; Babarykin DA; Tikhomirova TE; Il'inskiĭ IM; Chernevskis KhK
    Ter Arkh; 1986; 58(1):105-8. PubMed ID: 3961679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Radiography of the hands, with a mammographic technic, in the study and supervision of renal osteodystrophy. Patients undergoing periodic hemodialysis].
    Bedani PL; Tamarozzi R; Farinelli R; Perini L; De Paoli Vitali E; Gilli P; Squerzanti R; Farinelli A
    Minerva Nefrol; 1983; 30(1):43-50. PubMed ID: 6843885
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of low dose 1 alpha-hydroxycholecalciferol on glomerular filtration rate in moderate renal failure.
    Eke FU; Winterborn MH
    Arch Dis Child; 1983 Oct; 58(10):810-3. PubMed ID: 6357106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [1 alpha-hydroxycholecalciferol in treatment of renal osteodystrophy].
    Chalmers TM; Davie MW; Hunter JO; Szaz KF
    J Urol Nephrol (Paris); 1974 Dec; 80(12):981. PubMed ID: 4617778
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevention of metabolic bone disease in the pre-end-stage renal disease setting.
    Coburn JW; Elangovan L
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S71-7. PubMed ID: 11443772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Etiology and pathology of metabolic bone diseases: renal osteodystrophy].
    Shigematsu T; Ogura Y
    Nihon Rinsho; 1986 Nov; 44(11):2428-36. PubMed ID: 3546796
    [No Abstract]   [Full Text] [Related]  

  • 39. Evolution of renal osteodystrophy: correlation of bone histomorphometry and serum mineral and immunoreactive parathyroid hormone values before and after treatment with calcium carbonate or 25-hydroxycholecalciferol.
    Bordier PJ; Marie PJ; Arnaud CD
    Kidney Int Suppl; 1975 Jan; (2):102-12. PubMed ID: 1057669
    [No Abstract]   [Full Text] [Related]  

  • 40. [Vitamin D in renal insufficiency--metabolism, hormonal forms, its effect and importance in the therapy of renal osteodystrophy].
    Labos I
    Med Arh; 1986; 40(3):101-4. PubMed ID: 3272310
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.